Although FLI1 might be downregulated in tumor mass, it is exerted as an immune regulator by targeting immune cells’ receptors or ligands expression in tumor mass, further affecting the communication of cells infiltrated in the tumor. This evidence concerns the gene FLI1 and neoplasm.